Allegria Therapeutics is a startup based in Switzerland, most recent round Seed.
Allegria Therapeutics is a company headquartered in Switzerland. Its most recent tracked round is Seed.
Allegria Therapeutics is a Basel-based biotechnology company developing therapies that target mast cell dysfunction. The company focuses on acute and chronic mast-cell–driven diseases, including allergic and inflammatory conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.